You are here

Article info

Article menu

Download PDFPDF

Commentary
It’s a long way to the top (if you want to personalize immunotherapy)

Authors

  • Sarah Haebe Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF)Ludwig-Maximilians-University Max-Lebsche Platz 30 81377 Munich Germany PubMed articlesGoogle scholar articles
  • Oliver Weigert Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF)Ludwig-Maximilians-University Max-Lebsche Platz 30 81377 Munich Germany German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany PubMed articlesGoogle scholar articles
  1. ↵b +49.89.4400.43985 oliver.weigert{at}med.uni-muenchen.de
View Full Text

Citation

Haebe S, Weigert O
It’s a long way to the top (if you want to personalize immunotherapy)
Journal for ImmunoTherapy of Cancer 2017;5:6. doi: 10.1186/s40425-016-0207-0

Publication history

  • Received November 23, 2016
  • Accepted December 28, 2016
  • First published January 17, 2017.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.